Super
Thanks. I missed the bit about the extras not being included. I was looking at this definition . . .
A requirement for SD is that it should be met at least once no less than 6-8 weeks after the first dose of trial treatment/baseline assessment, otherwise the best response will be Not Evaluable (NE). The criteria for confirmation of the response is summarized in the following table: . . .
When they said that 10 patients were evaluable, I was placing the other 4 patients in the above definition.
If you're interested, I took that from here https://www.phusewiki.org/wiki/index.php?title=Best_Overall_Tumor_Response_for_Solid_Tumours
Cheers
SuperThanks. I missed the bit about the extras not being...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.8¢ | $134.8K | 3.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 1738258 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 494405 | 4 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
